{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:41:45Z","timestamp":1784018505601,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1245\/s10434-019-07690-4","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T17:02:58Z","timestamp":1565197378000},"page":"3955-3961","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Age and Lymphovascular Invasion Accurately Predict Sentinel Lymph Node Metastasis in T2 Melanoma Patients"],"prefix":"10.1245","volume":"26","author":[{"given":"Michael E.","family":"Egger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Bhutiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne C.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Scoggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prejesh","family":"Philips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Robert C. G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"McMasters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"key":"7690_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1245\/s10434-017-6267-7","volume":"25","author":"SL Wong","year":"2018","unstructured":"Wong SL, Faries MB, Kennedy EB, et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. Ann Surg Oncol. 2018;25:356\u201377.","journal-title":"Ann Surg Oncol"},{"key":"7690_CR2","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1002\/cncr.24660","volume":"115","author":"C Gajdos","year":"2009","unstructured":"Gajdos C, Griffith KA, Wong SL, et al. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer. 2009;115:5752\u201360.","journal-title":"Cancer"},{"key":"7690_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/archsurg.2010.115","volume":"145","author":"CR Scoggins","year":"2010","unstructured":"Scoggins CR, Bowen AL, Martin RC II, et al. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma. Arch Surg. 2010;145:622\u20137.","journal-title":"Arch Surg"},{"key":"7690_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/SLA.0000000000000500","volume":"260","author":"AP van der Ploeg","year":"2014","unstructured":"van der Ploeg AP, Haydu LE, Spillane AJ, et al. Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution. Ann Surg. 2014;260:149\u201357.","journal-title":"Ann Surg"},{"key":"7690_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599\u2013609.","journal-title":"N Engl J Med"},{"key":"7690_CR6","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1245\/s10434-014-3954-5","volume":"21","author":"SD Kachare","year":"2014","unstructured":"Kachare SD, Brinkley J, Wong JH, Vohra NA, Zervos EE, Fitzgerald TL. The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma. Ann Surg Oncol. 2014;21:3377\u201385.","journal-title":"Ann Surg Oncol"},{"key":"7690_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","volume":"17","author":"U Leiter","year":"2016","unstructured":"Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17:757\u201367.","journal-title":"Lancet Oncol"},{"key":"7690_CR8","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376:2211\u201322.","journal-title":"N Engl J Med"},{"key":"7690_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1245\/ASO.2004.03.044","volume":"11","author":"VK Sondak","year":"2004","unstructured":"Sondak VK, Taylor JM, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol. 2004;11:247\u201358.","journal-title":"Ann Surg Oncol"},{"key":"7690_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1067\/msy.2001.115830","volume":"130","author":"KM McMasters","year":"2001","unstructured":"McMasters KM, Wong SL, Edwards MJ, et al. Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery. 2001;130:151\u20136.","journal-title":"Surgery"},{"key":"7690_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1245\/s10434-013-3464-x","volume":"21","author":"CM Balch","year":"2014","unstructured":"Balch CM, Thompson JF, Gershenwald JE, et al. Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol. 2014;21:1075\u201381.","journal-title":"Ann Surg Oncol"},{"key":"7690_CR12","unstructured":"Amin MB, Edge SB, American Joint Committee on Cancer. AJCC Cancer Staging Manual. 8th ed. Springer, Switzerland, 2017."},{"key":"7690_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jso.20084","volume":"86","author":"KM McMasters","year":"2004","unstructured":"McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol. 2004;86:212\u201323.","journal-title":"J Surg Oncol"},{"key":"7690_CR14","volume-title":"Classification and regression trees","author":"L Breiman","year":"1984","unstructured":"Breiman L, Friedman J, Stone CJ, Olshen RA. Classification and regression trees. Boca Raton, FL: Taylor & Francis; 1984"},{"key":"7690_CR15","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jamadermatol.2017.2497","volume":"153","author":"AJ Sinnamon","year":"2017","unstructured":"Sinnamon AJ, Neuwirth MG, Yalamanchi P, et al. Association between patient age and lymph node positivity in thin melanoma. JAMA Dermatol. 2017;153:866\u201373.","journal-title":"JAMA Dermatol"},{"key":"7690_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jamcollsurg.2018.12.030","volume":"228","author":"ME Egger","year":"2019","unstructured":"Egger ME, Stevenson M, Bhutiani N, et al. Should sentinel lymph node biopsy be performed for all T1b melanomas in the new 8(th)-Edition American Joint Committee on Cancer Staging System? J Am Coll Surg. 2019;228:466\u201372.","journal-title":"J Am Coll Surg"},{"key":"7690_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jaad.2018.08.051","volume":"80","author":"RZ Conic","year":"2019","unstructured":"Conic RZ, Ko J, Damiani G, et al. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database. J Am Acad Dermatol. 2019;80:441\u20137","journal-title":"J Am Acad Dermatol."},{"key":"7690_CR18","unstructured":"National Comprehensive Cancer Network. Cutaneous Melanoma (Version 1.2019). \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cutaneous_melanoma.pdf\n                    \n                  . Retrieved 20 Nov 2018."},{"key":"7690_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1245\/s10434-015-4766-y","volume":"23","author":"EK Bartlett","year":"2016","unstructured":"Bartlett EK, Peters MG, Blair A, et al. Identification of patients with intermediate-thickness melanoma at low risk for sentinel lymph node positivity. Ann Surg Oncol. 2016;23:250\u20136.","journal-title":"Ann Surg Oncol"},{"key":"7690_CR20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.amjsurg.2017.12.009","volume":"215","author":"JM Chang","year":"2018","unstructured":"Chang JM, Kosiorek HE, Dueck AC, et al. Stratifying SLN incidence in intermediate-thickness melanoma patients. Am J Surg. 2018;215:699\u2013706.","journal-title":"Am J Surg"},{"key":"7690_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/cncr.22382","volume":"109","author":"SC Paek","year":"2007","unstructured":"Paek SC, Griffith KA, Johnson TM, et al. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer. 2007;109:100\u20138.","journal-title":"Cancer"},{"key":"7690_CR22","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/cncr.24895","volume":"116","author":"MP Mays","year":"2010","unstructured":"Mays MP, Martin RC, Burton A, et al. Should all patients with melanoma between 1- and 2-mm Breslow thickness undergo sentinel lymph node biopsy? Cancer. 2010;116:1535\u201344.","journal-title":"Cancer"},{"key":"7690_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jaad.2018.08.022","volume":"80","author":"AN Hanna","year":"2019","unstructured":"Hanna AN, Sinnamon AJ, Roses RE, et al. Relationship between age and likelihood of lymph node metastases in patients with intermediate-thickness melanoma (1.01\u20134.00\u00a0mm): a National Cancer Database study. J Am Acad Dermatol. 2019;80:433\u201340.","journal-title":"J Am Acad Dermatol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07690-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07690-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07690-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T23:04:48Z","timestamp":1596668688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07690-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["7690"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07690-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,7]]},"assertion":[{"value":"30 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kelly M. McMasters serves on the Scientific Advisory Board for Elucida Oncology. The National Cancer Data Base (NCDB) is a joint project of the Commission on Cancer (CoC) of the American College of Surgeons and the American Cancer Society. The CoC\u2019s NCDB and the hospitals participating in the CoC NCDB are the source of the de-identified data used in this study. They have not verified the statistical validity of the data analysis or the conclusions derived by the authors and are not responsible for these.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}